QS Investors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

QS Investors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,905	Closed	-$1.07M	–	1260
2020 Q4	$1.07M	Sell	13,905 -166	-1%	-$12.4K	0.01%	481
2020 Q3	$1.05M	Sell	14,071 -47,464	-77%	-$3.16M	0.01%	437
2020 Q2	$3.87M	Sell	61,535 -1,800	-3%	-$99K	0.05%	278
2020 Q1	$2.66M	Hold	63,335	–	–	0.04%	326
2019 Q4	$2.93M	Sell	63,335 -150	-0.2%	-$7.09K	0.03%	456
2019 Q3	$2.91M	Hold	63,485	–	–	0.03%	430
2019 Q2	$3.72M	Buy	63,485 +33,681	+113%	+$1.74M	0.04%	359
2019 Q1	$1.34M	Buy	29,804 +2,244	+8%	+$103K	0.01%	733
2018 Q4	$1.07M	Hold	27,560	–	–	0.01%	744
2018 Q3	$1.27M	Hold	27,560	–	–	0.01%	755
2018 Q2	$1.2M	Sell	27,560 -585	-2%	-$25.1K	0.01%	742
2018 Q1	$1.11M	Sell	28,145 -2,811	-9%	-$109K	0.01%	761
2017 Q4	$1.05M	Hold	30,956	–	–	0.01%	792
2017 Q3	$789K	Buy	+30,956	New	+$710K	0.01%	848
2017 Q2	–	Sell	-30,956	Closed	-$452K	–	2065
2017 Q1	$452K	Hold	30,956	–	–	﹤0.01%	992
2016 Q4	$440K	Hold	30,956	–	–	﹤0.01%	914
2016 Q3	$542K	Hold	30,956	–	–	﹤0.01%	872
2016 Q2	$529K	Hold	30,956	–	–	﹤0.01%	890
2016 Q1	$610K	Hold	30,956	–	–	0.01%	867
2015 Q4	$588K	Hold	30,956	–	–	0.01%	876
2015 Q3	$591K	Hold	30,956	–	–	0.01%	857
2015 Q2	$1.44M	Hold	30,956	–	–	0.02%	685
2015 Q1	$1.35M	Hold	30,956	–	–	0.02%	680
2014 Q4	$1.07M	Buy	+30,956	New	+$1.26M	0.01%	712

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

QS Investors's ARNA Position: Q1 2021 in Review

QS Investors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 13,905 shares — an estimated $1.07M sold.

QS Investors first reported a position in ARNA in Q4 2014 and held it in 24 quarters. The position peaked at $3.87M in Q2 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

QS Investors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
QS Investors sold 13,905 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $1.07M.
QS Investors first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 24 quarters.
QS Investors's Arena Pharmaceuticals Inc position peaked at $3.87M in Q2 2020.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.